Literature DB >> 18300212

Development and validation of a reversed-phase HPLC method for quantitative determination of ginsenosides Rb1, Rd, F2, and compound K during the process of biotransformation of ginsenoside Rb1.

Wei Zhou1, Jiyang Li, Xinwei Li, Qin Yan, Pei Zhou.   

Abstract

A simple and rapid gradient RP-HPLC method for simultaneous separation and determination of related ginsenosides during the process of biotransformation of ginsenoside Rb1 has been developed. As many as four process ginsenosides have been separated and identified on an Eclipse XDB C(18) column (4.6 mm x 150 mm, 5 mum) with gradient elution using water and ACN as a mobile phase. The column was maintained at 30 degrees C and the eluents were monitored with diode array detection at 203 nm. The method was validated in terms of linearity, sensitivity, precision, and accuracy. The correlation coefficients (r) for calibration curves of ginsenosides were in the range of 0.9996-1.0000. The proposed RP-HPLC method was successfully applied to the analysis of fermentation broth and the recoveries of ginsenosides were in the range of 94.4-103.1% with RSD <2.87%. The method could be of use for rapid and routine evaluation of the quantity of ginsenosides during the biotransformation process of ginsenoside Rb1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300212     DOI: 10.1002/jssc.200700406

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  8 in total

Review 1.  Functional Mechanism of Ginsenoside Compound K on Tumor Growth and Metastasis.

Authors:  Jinlong Liu; Yuchen Wang; Zhun Yu; Guangfu Lv; Xiaowei Huang; He Lin; Chao Ma; Zhe Lin; Peng Qu
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

Review 2.  Current evaluation of the millennium phytomedicine--ginseng (I): etymology, pharmacognosy, phytochemistry, market and regulations.

Authors:  Lee Jia; Yuqing Zhao
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

3.  UPLC-MS/MS Determination of Twelve Ginsenosides in Shenfu Tang and Dushen Tang.

Authors:  Dawai Yang; Xiaofang Yang; Han Yan; Bin Fan; Jingang Dai; Jun Song; Yan Lei; Na Guo
Journal:  Int J Anal Chem       Date:  2019-07-11       Impact factor: 1.885

4.  Polymorphic Characterization, Pharmacokinetics, and Anti-Inflammatory Activity of Ginsenoside Compound K Polymorphs.

Authors:  Yun-Yan Kuang; Xuan Gao; Yi-Jun Niu; Xun-Long Shi; Wei Zhou
Journal:  Molecules       Date:  2021-04-01       Impact factor: 4.411

5.  Ginsenoside Compound K Enhances Fracture Healing via Promoting Osteogenesis and Angiogenesis.

Authors:  Lingli Ding; Song Gu; Bingyu Zhou; Min Wang; Yage Zhang; Siluo Wu; Hong Zou; Guoping Zhao; Zhao Gao; Liangliang Xu
Journal:  Front Pharmacol       Date:  2022-04-01       Impact factor: 5.988

6.  Development and validation of an LC-MS/MS method for determination of compound K in human plasma and clinical application.

Authors:  Jung Soo Kim; Yunjeong Kim; Song-Hee Han; Ji-Young Jeon; Minho Hwang; Yong-Jin Im; Jung Hyun Kim; Sun Young Lee; Soo-Wan Chae; Min-Gul Kim
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

7.  Determination of ginsenoside compound K in human plasma by liquid chromatography-tandem mass spectrometry of lithium adducts.

Authors:  Yunhui Chen; Youming Lu; Yong Yang; Xiaoyan Chen; Liang Zhu; Dafang Zhong
Journal:  Acta Pharm Sin B       Date:  2015-08-19       Impact factor: 11.413

8.  New metabolites from the biotransformation of ginsenoside Rb1 by Paecilomyces bainier sp.229 and activities in inducing osteogenic differentiation by Wnt/β-catenin signaling activation.

Authors:  Wei Zhou; Hai Huang; Haiyan Zhu; Pei Zhou; Xunlong Shi
Journal:  J Ginseng Res       Date:  2017-03-22       Impact factor: 6.060

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.